Pargyline

monoamine oxidase B ; Homo sapiens







28 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34641548 Selected Class of Enamides Bearing Nitro Functionality as Dual-Acting with Highly Selective Monoamine Oxidase-B and BACE1 Inhibitors. 2021 Oct 3 1
2 28685208 Iron modulates the activity of monoamine oxidase B in SH-SY5Y cells. 2017 Aug 1
3 26263056 Inhibitive activities detection of monoamine oxidases (MAO) A and B inhibitors in human liver MAO incubations by UPLC-ESI-MS/MS. 2015 Nov 10 1
4 23499958 Acute effects of resveratrol to enhance cocaine-induced dopamine neurotransmission in the striatum. 2013 May 10 1
5 21341713 Topological probes of monoamine oxidases A and B in rat liver mitochondria: inhibition by TEMPO-substituted pargyline analogues and inactivation by proteolysis. 2011 Apr 5 1
6 19789505 Monoamine oxidase and semicarbazide sensitive amine oxidase activities in normal and inflamed human dental pulp. 2009 Oct 1
7 17030739 Structure of the human mitochondrial monoamine oxidase B: new chemical implications for neuroprotectant drug design. 2006 Oct 10 1
8 15279562 Structure and mechanism of monoamine oxidase. 2004 Aug 1
9 12777388 Structural comparison of human monoamine oxidases A and B: mass spectrometry monitoring of cysteine reactivities. 2003 Aug 1 2
10 11753429 Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders. 2002 Jan 1
11 9564606 Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline). 1998 2
12 9503561 [Discovery of monoamine oxidase forms A and B]. 1997 Nov-Dec 1
13 7953696 The MAO-B inhibitor deprenyl, but not the MAO-A inhibitor clorgyline, potentiates the neurotoxicity of p-chloroamphetamine. 1994 Jul 11 1
14 1413647 [Multiple forms of monoamine oxidase in the growing human placenta]. 1992 May-Jun 1
15 1686901 Synthesis, biological evaluation and quantitative structure activity relationship analysis of nuclear-substituted pargylines as competitive inhibitors of MAO-A and MAO-B. 1991 Nov 1
16 2111588 Pargyline-sensitive selective accumulation of a radiolabeled MPTP analog in the primate cerebral cortex and basal ganglia. 1990 1
17 2963592 The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: role of intracellular calcium. 1988 Feb 1 1
18 3566791 Photoaffinity labeling of beef liver monoamine oxidase-B by 4-fluoro-3-nitrophenyl azide. 1987 Mar 15 2
19 20501066 4-Fluoro-3-nitrophenyl azide binding sites on purified beef liver monoamine oxidase B. 1987 1
20 3011983 The interaction of 1-alkyl-4,4-diphenylpiperidines with the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine receptor binding site. 1986 1
21 3527152 Monoclonal antibodies to monoamine oxidase B and another mitochondrial protein from human liver. 1986 Apr 1 1
22 6335034 Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP. 1984 Dec 14 1
23 6191193 Use of a monoclonal antibody for comparative studies of monoamine oxidase B in mitochondrial extracts of human brain and peripheral tissues. 1983 Jul 1
24 6359210 An open trial of pargyline in the treatment of attention deficit disorder, residual type. 1983 Aug 1
25 6822482 Pargyline-induced mania in primary affective disorder: case report. 1983 Jan 1
26 6791210 Tyramine infusions and selective monoamine oxidase inhibitor treatment. II. Interrelationships among pressor sensitivity changes, platelet MAO inhibition, and plasma MHPG reduction. 1981 2
27 7264664 Differences in the structure of A and B forms of human monoamine oxidase. 1981 Aug 1
28 111275 Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in man. 1979 Apr 11 1